Nonstimulant ADHD medication wins approval: first new drug type for disorder in 30 years. (Atomoxetine Not a Controlled Substance).(attention-deficit ... disorder): An article from: Pediatric News
Book Details
Author(s)
Kerri Wachter
Publisher
International Medical News Group
ISBN / ASIN
B0008G5OL6
ISBN-13
978B0008G5OL3
Availability
Available for download now
Sales Rank
#9,873,623
Marketplace
United States 🇺🇸
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from Pediatric News, published by International Medical News Group on January 1, 2003. The length of the article is 1004 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Nonstimulant ADHD medication wins approval: first new drug type for disorder in 30 years. (Atomoxetine Not a Controlled Substance).(attention-deficit hyperactivity disorder)
Author: Kerri Wachter
Publication:Pediatric News (Magazine/Journal)
Date: January 1, 2003
Publisher: International Medical News Group
Volume: 37 Issue: 1 Page: 1(2)
Article Type: Product/Service Evaluation
Distributed by Thomson Gale
Citation Details
Title: Nonstimulant ADHD medication wins approval: first new drug type for disorder in 30 years. (Atomoxetine Not a Controlled Substance).(attention-deficit hyperactivity disorder)
Author: Kerri Wachter
Publication:Pediatric News (Magazine/Journal)
Date: January 1, 2003
Publisher: International Medical News Group
Volume: 37 Issue: 1 Page: 1(2)
Article Type: Product/Service Evaluation
Distributed by Thomson Gale
